Alvotech will conduct a business update conference call and live webcast on Thursday March 27, 2025, at 8:00 am ET (12:00pm ...

Kedaara Capital and TA Associates are in talks to acquire a significant minority stake in Sagent Pharma, valued at $500-600 ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Alvotech acquires Xbrane’s R&D operations and the biosimilar candidate XB003. Xbrane retains some pre-clinical development programs, that it intends to commercialize, and will continue operating as a ...

Patients with diabetic macular edema previously treated with a ranibizumab biosimilar in India experience comparable safety ...

“The FDA's filing acceptance of Dr. Reddy's proposed denosumab biosimilar marks an important milestone in bringing this biosimilar medication to more patients throughout the U.S.,” said Milan ...

Patients should avoid food allergens when taking the drug, according to the FDA. Finally, the biosimilar agent can be used for patients with chronic spontaneous urticaria — ongoing unexplained ...

The FDA defines a biosimilar as a biological product that is highly similar to an FDA-approved brand-name biologic drug (known as the reference product) used in the prevention or treatment of disease.

Objectives: Biosimilars offer a promising solution to challenges related to healthcare budget sustainability. However, limited patient awareness and understanding often hinder their timely adoption.

The arrival of biosimilars like Celltrion's STEQEYMA and Biocon's YESINTEK is shaking up the psoriatic arthritis market, challenging blockbuster biologics with cost-effective alternatives. As ...

ESPN ranked the top 100 free agents ahead of the busy week. Below is a complete list of the available unrestricted free agents before the start of the legal tampering period, sorted by team.

Findings showed equivalent efficacy in change from baseline in weekly itch severity score between omalizumab-igec 300mg and Xolair 300mg. The Food and Drug Administration (FDA) has approved ...